ArticleCancer medicine2024

Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma.

Angela E Alnemri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.